Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia

Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

NCT06763744 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

NCT05320926 ·Status: RECRUITING ·Phase: NA

Platelet Reactivity After Receiving Clopidogrel Among Moderate CKD Patients Undergoing PCI

NCT02556671 ·Status: UNKNOWN

Genotype Guided Antiplatelet Therapy In Ischemic Stroke

NCT05763862 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation

NCT02494284 ·Status: TERMINATED ·Phase: PHASE4

Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease

NCT04001894 ·Status: COMPLETED ·Phase: PHASE4

PACT (Platelet Activity After Clopidogrel Termination)

NCT00619073 ·Status: COMPLETED ·Phase: NA

Monitoring Antiplatelet Drugs in Cardiac Arrest Patients

NCT05730114 ·Status: UNKNOWN

Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity

NCT03062462 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis

NCT00914368 ·Status: COMPLETED ·Phase: PHASE2

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents

NCT03056118 ·Status: COMPLETED ·Phase: PHASE4

Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES

NCT05770674 ·Status: RECRUITING ·Phase: NA

Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES

NCT02079194 ·Status: UNKNOWN ·Phase: NA

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

NCT00391872 ·Status: COMPLETED ·Phase: PHASE3

Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects

NCT02171598 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects

NCT02560688 ·Status: COMPLETED ·Phase: PHASE1

Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm

NCT02675205 ·Status: COMPLETED ·Phase: PHASE3

Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.

NCT04619927 ·Status: UNKNOWN ·Phase: PHASE4

Time Based Strategy to Reduce Clopidogrel Associated Bleeding Related to Coronary Artery Bypass Graft (CABG)

NCT00857155 ·Status: UNKNOWN ·Phase: NA

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

NCT06283888 ·Status: RECRUITING ·Phase: PHASE4

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI

NCT03437044 ·Status: COMPLETED ·Phase: PHASE4

Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD

NCT03614832 ·Status: UNKNOWN ·Phase: PHASE4

Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients

NCT06276374 ·Status: RECRUITING ·Phase: NA

Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities

NCT02217501 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders

NCT00642811 ·Status: COMPLETED ·Phase: PHASE2